Vol.

No.

March 08, 2019Mar 08, 2019

Free

DOWNLOAD THE PDF

Trump's proposal for pediatric cancer has NCI envisioning the first data federation of its kind

Cover Story

Free

Trump's proposal for pediatric cancer has NCI envisioning the first data federation of its kind

By Matthew Bin Han Ong

In anticipation of an infusion of funds from Congress, NCI is developing a blueprint for a comprehensive cancer data federation—starting with pediatric cancer.

Conversation with The Cancer Letter Free

Sharpless: With $500 million, NCI can create data federation that would change research in childhood cancer

By Matthew Bin Han Ong

Conversation with The Cancer Letter Free

CHOP's Resnick: Big data will transition from research to the standard of care in the clinic

By Matthew Bin Han Ong

Conversation with The Cancer Letter Free

St. Jude's Roberts: “No single institution can maximize cures and minimize toxicities alone”

By Matthew Bin Han Ong

Free Guest Editorial

Needed: A fully funded data federation for pediatric cancer with deep genomic sequencing and clinical records

By Nancy Goodman

Gottlieb resigns at FDA, recommends Sharpless as successor

By Paul Goldberg

In Brief

Raymond DuBois receives AACR Margaret Foti Award

Charles Sawyers to present AACR Princess Takamatsu memorial lecture

Alberto Mantovani receives Pezcoller Foundation-AACR Award

Jeffrey Bluestone to receive AACR-Irving Weinstein Foundation lectureship award

Manuel Hidalgo named chief of hematology and medical oncology at Weill Cornell

Greg Delgoffe to receive Sy Holzer Endowed Immunotherapy Research Fund

Funding Opportunities

FDA Oncology Center of Excellence publishes research contract opportunities

Clinical Roundup

Genentech submits sNDA for Venclexta plus Gazyva for previously untreated CLL

Study: AI may perform as well as radiologists

Drugs & Targets

Paige.AI receives FDA Breakthrough Device designation

Lynparza receives positive EU CHMP opinion in breast cancer

Breast Cancer Index receives expanded Medicare coverage

NCI Trials

NCI Trials for March

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 43 - November 15, 2024

Trump's proposal for pediatric cancer has NCI envisioning the first data federation of its kind

Sharpless: With $500 million, NCI can create data federation that would change research in childhood cancer

CHOP's Resnick: Big data will transition from research to the standard of care in the clinic

St. Jude's Roberts: “No single institution can maximize cures and minimize toxicities alone”

Needed: A fully funded data federation for pediatric cancer with deep genomic sequencing and clinical records

Gottlieb resigns at FDA, recommends Sharpless as successor

In Brief

Raymond DuBois receives AACR Margaret Foti Award

Charles Sawyers to present AACR Princess Takamatsu memorial lecture

Alberto Mantovani receives Pezcoller Foundation-AACR Award

Jeffrey Bluestone to receive AACR-Irving Weinstein Foundation lectureship award

Manuel Hidalgo named chief of hematology and medical oncology at Weill Cornell

Greg Delgoffe to receive Sy Holzer Endowed Immunotherapy Research Fund

Funding Opportunities

FDA Oncology Center of Excellence publishes research contract opportunities

Clinical Roundup

Genentech submits sNDA for Venclexta plus Gazyva for previously untreated CLL

Study: AI may perform as well as radiologists

Drugs & Targets

Paige.AI receives FDA Breakthrough Device designation

Lynparza receives positive EU CHMP opinion in breast cancer

Breast Cancer Index receives expanded Medicare coverage

NCI Trials

NCI Trials for March

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login